PPARα
|
liver, brown fat, kidney, heart, skeletal muscle |
fibrates fatty acids (e.g., oleic acid, palmitic acid) eicosanoids (e.g., arachidonic acid) |
p300, c/EBP, SRC-1, PBP, PGC-1, PRIP |
lipid catabolism, inflammatory responses, lipoprotein metabolism |
hepatomegaly, liver tumors, impaired wound healing, prolonged inflammatory responses, increased adipose tissue |
|
PPARδ
|
gut, kidney, brain, heart, skeletal muscle |
fatty acids, NSAIDS (antagonist) |
SRC-1, PBP |
fatty acid β-oxidation, bone metabolism, tumorigenesis, vascular integrity |
fatal placental defects from abnormal vasculature, small healthy adults |
|
PPARγ
|
adipose tissue, cartilage, osteoblasts, epithelial cells, prostate, large intestine, monocytes, kidney |
thiazolinediones eicosanoids (e.g., 15d-PGJ2, 15-HETE) fatty acids (e.g., DHA, linoleic acid) |
p300, c/EBP, SRC-1, PBP, PGC-1, PRIP |
adipogenesis, inflammatory response, insulin sensitization, differentiation |
embryo-fatal, placenta fails to implant and develop, severe metabolic, hepatic, intestinal, adipogenic, abnormalities |